How Site And Patient Research Optimizes Clinical Trials

By Katie Garner, Advisor - Therapeutic Areas

Digital health technology (DHT) solutions are revolutionizing the clinical trial industry, but it is crucial to ensure that these technologies meet the needs of patients and research sites. Signant Health, a leader in DHT solutions, conducts extensive qualitative research with sponsors, sites, and trial participants to gather feedback on their solutions' features, design, usability, and training. This research helps shape their solutions and services to optimize patient and site use.

Signant Health's research includes primary research with participant groups and clinical trial site staff, as well as secondary research to gather insights from other sources. By gathering feedback and insights from patients and sites, Signant Health can improve the usability and functionality of its solutions, making it easier for participants to engage in clinical trials.

The article emphasizes the importance of user testing in evaluating the usability and acceptability of medical devices and apps used in clinical trials. It highlights the benefits of conducting research with stakeholders, such as sponsors and sites, to gain valuable insights and identify areas for improvement. The findings from this research can be used to guide product development, optimize solution design, enhance training materials, verify hardware suitability, and contribute to industry knowledge.